MedVellum
MedVellum
Back to Library
Geriatric Medicine
Psychiatry
Primary Care

Behavioural and Psychological Symptoms of Dementia (BPSD)

High EvidenceUpdated: 2025-12-22

On This Page

Red Flags

  • Exclude pain, infection, constipation (delirium)
  • Sudden change in behaviour
  • Risk to self or others
Overview

Behavioural and Psychological Symptoms of Dementia (BPSD)

1. Clinical Overview

Summary

Behavioural and Psychological Symptoms of Dementia (BPSD) refers to a range of non-cognitive symptoms affecting people with dementia, including agitation, aggression, wandering, sleep disturbance, depression, anxiety, psychosis (hallucinations and delusions), apathy, and sexually inappropriate behaviour. BPSD affects up to 90% of dementia patients at some point and is a major cause of distress for patients, carers, and staff. The first step in management is always to identify and treat underlying causes (pain, infection, constipation). Non-pharmacological approaches are first-line. Antipsychotics (e.g., risperidone) are used cautiously for severe symptoms due to increased risk of stroke and mortality.

Key Facts

  • Prevalence: Up to 90% of dementia patients at some stage
  • Symptoms: Agitation, Aggression, Wandering, Psychosis, Depression, Apathy, Sleep disturbance
  • First Step: Rule out delirium, pain, infection, constipation
  • First-Line: Non-pharmacological interventions
  • Medication: Risperidone (short-term, lowest dose) — increased stroke/mortality risk
  • Assessment: Cohen-Mansfield Agitation Inventory

Clinical Pearls

"Always Think: Pain, Infection, Constipation": Behaviour change in dementia often reflects an unmet need. Rule out medical causes first.

"Delirium on Dementia": A sudden change in behaviour in a dementia patient is delirium until proven otherwise. Look for infection, medication changes, urinary retention.

"Low and Slow": If antipsychotics are needed, use the lowest effective dose for the shortest possible time. Risperidone is licensed for BPSD.

"Antipsychotics Carry Risk": Antipsychotics increase mortality and stroke risk in dementia. Document the discussion with patient/family.


2. Epidemiology

Prevalence

  • 60-90% of dementia patients experience BPSD at some stage
  • Increases with disease severity

Common Symptoms

SymptomPrevalence
Apathy50-70%
Agitation40-60%
Depression30-50%
Anxiety30-50%
Delusions20-40%
Hallucinations10-30%
Wandering20-40%

3. Pathophysiology

Causes of BPSD

CategoryExamples
Unmet NeedPain, hunger, thirst, toileting, boredom, loneliness
EnvironmentOverstimulation, understimulation, unfamiliar place
MedicalInfection (UTI, chest), Constipation, Medication side effects, Delirium
PsychiatricDepression, Anxiety, Psychosis
NeurologicalFrontal lobe disinhibition, Cholinergic deficits

Neurobiological Basis

  • Frontal lobe dysfunction (disinhibition)
  • Temporal lobe pathology (psychosis)
  • Cholinergic and serotonergic deficits

4. Clinical Presentation

Behavioural Symptoms

SymptomDescription
AgitationRestlessness, pacing, repetitive movements
AggressionVerbal (shouting) or physical (hitting, biting)
WanderingPurposeless walking, attempts to leave
Sexually inappropriate behaviourDisinhibition
Screaming/VocalisationRepeated calling out

Psychological Symptoms

SymptomDescription
DelusionsOften paranoid (theft, infidelity)
HallucinationsVisual > auditory (especially Lewy body)
DepressionLow mood, withdrawal
AnxietyFearfulness, worrying
ApathyLack of interest, motivation
Sleep disturbanceReversal of day/night

5. Clinical Examination

General

  • Assess for pain (facial expressions, guarding)
  • Signs of infection (fever, cough, dysuria)
  • Hydration and nutrition

Mental State

  • Cognitive assessment (worsening dementia or delirium?)
  • Mood
  • Psychotic symptoms

Physical

  • Abdominal examination (constipation, urinary retention)
  • Chest examination
  • Review medication chart

6. Investigations

Rule Out Medical Cause

TestPurpose
Urinalysis / MSUUTI
FBC, CRPInfection
U&E, Ca, GlucoseMetabolic causes
Chest X-rayPneumonia
Medication reviewNew or inappropriate drugs
Pain assessmentUnrecognised pain

7. Management

Management Approach

┌──────────────────────────────────────────────────────────┐
│   BPSD MANAGEMENT                                        │
├──────────────────────────────────────────────────────────┤
│                                                          │
│  STEP 1: IDENTIFY AND TREAT UNDERLYING CAUSE             │
│  • Pain (trial of regular paracetamol)                   │
│  • Infection                                             │
│  • Constipation                                          │
│  • Medication side effects                               │
│  • Delirium                                              │
│                                                          │
│  STEP 2: NON-PHARMACOLOGICAL (FIRST-LINE)                 │
│  • Person-centred care                                   │
│  • Music therapy, aromatherapy                           │
│  • Structured activities                                 │
│  • Reduce noise/overstimulation                          │
│  • Familiar routines                                     │
│  • Address unmet needs                                   │
│  • Staff/carer training                                  │
│                                                          │
│  STEP 3: PHARMACOLOGICAL (IF SEVERE/RISK)                 │
│  • Antipsychotics (LAST RESORT):                         │
│    - Risperidone 250mcg BD (lowest dose, short-term)     │
│    - Licensed for BPSD (up to 6 weeks)                   │
│    - ⚠️ Increased stroke and mortality risk              │
│    - Document discussion with family                     │
│  • Antidepressants (Sertraline, Trazodone) for           │
│    depression/aggression                                 │
│  • Memantine may help agitation in Alzheimer's           │
│                                                          │
│  AVOID:                                                   │
│  • Benzodiazepines (worsen confusion, falls)             │
│  • Antipsychotics in Lewy body dementia                  │
│    (severe sensitivity reactions)                        │
│                                                          │
└──────────────────────────────────────────────────────────┘

8. Complications

Of BPSD

  • Falls and injuries (agitation, wandering)
  • Weight loss (refusal to eat)
  • Carer burnout
  • Institutionalisation

Of Treatment

  • Antipsychotics: Stroke, Parkinsonism, Sedation, Falls, Death
  • Higher mortality in dementia patients on antipsychotics

9. Prognosis & Outcomes

Natural History

  • BPSD fluctuates over time
  • Some symptoms improve spontaneously
  • Often worsens with disease progression

Impact

  • BPSD is more distressing to carers than cognitive decline
  • Major reason for care home admission

10. Evidence & Guidelines

Key Guidelines

  1. NICE NG97: Dementia (2018)
  2. Maudsley Prescribing Guidelines: Dementia

Key Evidence

Antipsychotics

  • CATIE-AD, DART-AD trials showed modest efficacy but increased mortality
  • Use only when severe risk; short-term

Non-Pharmacological

  • Growing evidence for person-centred care, music therapy

11. Patient/Layperson Explanation

What is BPSD?

BPSD stands for "Behavioural and Psychological Symptoms of Dementia." It includes things like agitation, aggression, wandering, depression, anxiety, and sometimes seeing or believing things that aren't there.

Why Does It Happen?

People with dementia may not be able to tell us when something is wrong. Changes in behaviour are often a sign of an unmet need — pain, hunger, needing the toilet, or just feeling scared or bored.

How is It Managed?

  • First: Rule out medical problems (infection, pain, constipation)
  • Non-drug approaches come first: Calm environment, activities, music, familiar routines
  • Medications (like risperidone) are used only as a last resort because they carry risks

What Should Carers Do?

  • Stay calm and reassuring
  • Try to understand the person's needs
  • Create a calm environment
  • Report any sudden changes to your GP

12. References

Primary Guidelines

  1. NICE. Dementia: Assessment, Management and Support for People Living with Dementia and Their Carers (NG97). 2018. nice.org.uk/guidance/ng97

Key Studies

  1. Ballard C, et al. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (DART-AD trial). PLoS Med. 2008. PMID: 18384229

Last updated: 2025-12-22

At a Glance

EvidenceHigh
Last Updated2025-12-22

Red Flags

  • Exclude pain, infection, constipation (delirium)
  • Sudden change in behaviour
  • Risk to self or others

Clinical Pearls

  • **"Always Think: Pain, Infection, Constipation"**: Behaviour change in dementia often reflects an unmet need. Rule out medical causes first.
  • **"Delirium on Dementia"**: A sudden change in behaviour in a dementia patient is delirium until proven otherwise. Look for infection, medication changes, urinary retention.
  • **"Low and Slow"**: If antipsychotics are needed, use the lowest effective dose for the shortest possible time. Risperidone is licensed for BPSD.
  • **"Antipsychotics Carry Risk"**: Antipsychotics increase mortality and stroke risk in dementia. Document the discussion with patient/family.
  • auditory (especially Lewy body) |

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines